title: Higher efavirenz plasma levels correlate with development of insomnia.
authors.forename: M
authors.initials: M
authors.lastname: Núñez
authors.forename: D
authors.initials: D
authors.lastname: González de Requena
authors.forename: L
authors.initials: L
authors.lastname: Gallego
authors.forename: I
authors.initials: I
authors.lastname: Jiménez-Nácher
authors.forename: J
authors.initials: J
authors.lastname: González-Lahoz
authors.forename: V
authors.initials: V
authors.lastname: Soriano
mesh_terms: D000480:Alkynes; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000097:blood; D048588:Benzoxazines; D003521:Cyclopropanes; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D010078:Oxazines / Q000009:adverse effects* / Q000097:blood; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000097:blood; D007319:Sleep Initiation and Maintenance Disorders / Q000139:chemically induced*
chemical_list: D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; C098320:efavirenz